Cardiac Surgery Market Size, Share & COVID19 Impact Analysis | Global | 2021-2027 | MedSuite | Includes: Tissue Heart Valve Market, TAVI/TAVR Market, and 15 more
- Year: 2021
- Scope: 10 Years
- Region: Global
- Pages: 958
- Type: MedSuite
In 2021, the global cardiac surgery market size is projected to reach over $14.2 billion, with the market for cerebral embolic protection devices showing the fastest growth in value. In spite of COVID19, the global market size is expected to increase over the forecast period and exceed $20.4 billion by 2027. Currently, the majority of the global market share is controlled by three main companies – Edwards Lifesciences, Medtronic, and Abbott.
One major trend in the global market for cardiac surgery devices is the shift towards minimally invasive procedures that improve patient health outcomes and reduces procedure complexity. Such procedures include transcatheter aortic valve implantation (TAVI) and transcatheter mitral valve repair (TMVR). Both market segments are set to grow substantially, with new competitors entering the markets with new products to capture the growing demand.
Market growth will be driven by the increased demand from a larger patient population. The aging population and expanded access to healthcare in emerging markets are analyzed among other key market drivers throughout the analysis.
HOW IS COVID19 IMPACTING THE CARDIAC SURGERY MARKET?
In 2020, the global market for cardiac surgery devices declined by over 11% when compared to 2019 as a result of the COVID-19 pandemic. However, the global market is expected to recover rapidly and exceed the pre-COVID levels by the end of 2021.
The cardiac surgery market was negatively impacted by COVID-19, as the many surgical procedures were deferred. For example, Transcatheter aortic valve replacement cases have been deferred if patients are asymptomatic, even in cases of critical aortic stenosis. Overall, the effects of the pandemic on the cardiac surgery and heart valve device market are expected to vary by market segment.
HOW MANY TAVI PROCEDURES ARE PERFORMED GLOBALLY?
Globally, there are over 190,000 transcatheter aortic valve implantation (TAVI) procedures performed every year, with North America and Western Europe having the highest demand.
Over the forecast period we expect an increase in procedural volume powered by the large population of patients who would benefit from TAVI, improved diagnostic capabilities, advancements in transcatheter aortic valve technology and the expanding indication for use of TAVI. The full report contains detailed analysis on procedure numbers for the additional market segments analyzed.
MARKET SEGMENTATION SUMMARY
While this global report suite contains all global cardiac surgery devices market data, each of the market segments is also available as a stand-alone report, MedCore.
- Tissue Heart Valve Market | Global | 2021-2027 | MedCore – The market analysis is further broken down into segments by:
- Device Type: Stented, Stentless, Sutureless/Rapid Deployment.
- Mechanical Heart Valve Market | Global | 2021-2027 | MedCore – The research includes an in-depth analysis of the global Mechanical Heart Valve Market;
- Annuloplasty Repair Device Market | Global | 2021-2027 | MedCore – The research includes an in-depth analysis of the global Annuloplasty Repair Device market;
- Transcatheter Mitral Valve Repair Market | Global | 2021-2027 | MedCore – The research includes an in-depth analysis of the global Transcatheter Mitral Valve Repair market;
- Transcatheter Aortic Valve Implantation Market | Global | 2021-2027 | MedCore – The research includes an in-depth analysis of the global Transcatheter Aortic Valve Implantation market;
- On-Pump Coronary Artery Bypass Device Market | Global | 2021-2027 | MedCore – The market analysis is further broken down into segments by:
- Device Type: ONCAB Disposables, Perfusion System.
- Off-Pump Coronary Artery Bypass Device Market | Global | 2021-2027 | MedCore – The market analysis is further broken down into segments by:
- Device Type: Stabilizer Device, Positioner Device.
- Autotransfusion Device Market | Global | 2021-2027 | MedCore – The market analysis is further broken down into segments by:
- Device Type: Autotransfusion Machine, Autotransfusion Disposables.
- Endoscopic Vessel Harvesting Device Market | Global | 2021-2027 | MedCore – The research includes an in-depth analysis of the global Endoscopic Vessel Harvesting Device Market;
- Anastomosis Assist Device Market | Global | 2021-2027 | MedCore – The research includes an in-depth analysis of the global Anastomosis Assist Device Market;
- Ventricular Assist Device Market | Global | 2021-2027 | MedCore – The market analysis is further broken down into segments by:
- Device Type: Percutaneous VAD (pVAD), Implantable VAD;
- Intra-Aortic Balloon Pump Device Market | Global | 2021-2027 | MedCore – The market analysis is further broken down into segments by:
- Device Type: IABP Catheter, IABP Console;
- Patent Foramen Ovale Closure Device Market | Global | 2021-2027 | MedCore – The research includes an in-depth analysis of the global Patent Foramen Ovale Closure Device Market;
- Atrial & Ventricular Septal Defect Closure Device Market | Global | 2021-2027 | MedCore – The market analysis is further broken down into segments by:
- Device Type: Atrial Septal Defect Closure Device, Ventricular Septal Defect Closure Device;
- Left Atrial Appendage Closure Device Market | Global | 2021-2027 | MedCore – The market analysis is further broken down into segments by:
- Device Type: Endocardial Device, Epicardial Device
- Pre-shaped Guidewire Market | Global | 2021-2027 | MedCore – The research includes an in-depth analysis of the global Pre-shaped Guidewire Market;
- Cerebral Embolic Protection Device Market | Global | 2021-2027 | MedCore – The research includes an in-depth analysis of the global Cerebral Embolic Protection Device Market;
WHO ARE THE TOP CARDIAC SURGERY COMPANIES?
The leaders in the cardiac surgery market are respectively Edwards Lifesciences, Medtronic, and Abbott. Together, they combine to make up a majority of the global market. The majority of Edwards Lifesciences’ market share comes from their strong presence in the tissue heart valves, annuloplasty repair devices, transcatheter mitral valve repair device and transcatheter aortic valve implantation devices.
GLOBAL RESEARCH SCOPE
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2020 |
| Forecast | 2021-2027 |
| Historical Data | 2017-2020 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
The Only Medical Device Market Research With: |
||||
|---|---|---|---|---|
| ✔ Procedure Volume Data & Trends ✔ Unit Sales Growth Analysis ✔ Average Selling Prices ✔ Competitor Shares by Segment ✔ SKU-Level Research Methods ✔ The Lowest Acquisition Cost |
 FREE Sample Report |
|||
TABLE OF CONTENTS I
LIST OF FIGURES XVI
LIST OF CHARTS XLII
EXECUTIVE SUMMARY 1
GLOBAL CARDIAC SURGERY AND HEART VALVE DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 8
MARKET DEVELOPMENTS 11
PROCEDURES INCLUDED 12
MARKETS INCLUDED 14
REGIONS INCLUDED 16
VERSION HISTORY 17
RESEARCH METHODOLOGY 18
Step 1: Project Initiation & Team Selection 18
Step 2: Prepare Data Systems and Perform Secondary Research 21
Step 3: Preparation for Interviews & Questionnaire Design 23
Step 4: Performing Primary Research 24
Step 5: Research Analysis: Establishing Baseline Estimates 26
Step 6: Market Forecast and Analysis 27
Step 7: Identify Strategic Opportunities 29
Step 8: Final Review and Market Release 30
Step 9: Customer Feedback and Market Monitoring 31
IMPACT OF COVID-19 ON THE GLOBAL CARDIAC SURGERY AND HEART VALVE DEVICE MARKET 32
2.1 INTRODUCTION 32
2.2 REGIONAL PROFILES 34
2.3 ANALYSIS BY MARKET SEGMENT 35
2.3.1 Worst Case Scenario 35
2.3.2 Base Case Scenario 38
2.3.3 Best Case Scenario 41
DISEASE OVERVIEW 45
3.1 BASIC ANATOMY 45
3.2 DISEASE TREATMENTS & DIAGNOSTICS 47
3.2.1 Coronary Artery Disease 47
3.2.2 Myocardial Infarction 47
3.2.3 Angina Pectoris 48
3.2.4 Heart Valve Disease 49
3.2.5 Congestive Heart Failure 49
3.2.6 Aortic Stenosis 50
3.2.7 Degenerative/Functional Mitral Regurgitation 52
3.3 PATIENT DEMOGRAPHICS 53
3.3.1 General Statistics 53
PRODUCT ASSESSMENT 54
4.1 INTRODUCTION 54
4.2 PRODUCT PORTFOLIOS 54
4.2.1 Tissue Heart Valve Device 54
4.2.2 Mechanical Heart Valve Device 57
4.2.3 Annuloplasty Repair Device 59
4.2.4 Transcatheter Mitral Valve Repair Device 61
4.2.5 Transcatheter Heart Valve Replacement Device 62
4.2.6 On-Pump Coronary Artery Bypass Device 64
4.2.7 Off-Pump Coronary Artery Bypass Device 66
4.2.8 Autotransfusion Device 67
4.2.9 Endoscopic Vessel Harvesting Device 69
4.2.10 Anastomosis Assist Device 70
4.2.11 Ventricular Assist Device 71
4.2.12 Intra-Aortic Balloon Pump Device 72
4.2.13 Patent Foramen Ovale Device 73
4.2.14 Atrial & Ventricular Septal Defect Device 74
4.2.15 Left Atrial Appendage Closure Device 75
4.2.16 Pre-shaped Guidewires 76
4.2.17 Cerebral Embolic Protection Device 77
4.3 REGULATORY ISSUES AND RECALLS 78
Abbott 78
Transcatheter Mitral Valve Repair Devices 78
Remote Hemodynamic Monitoring System Devices 79
Boston Scientific 80
Transcatheter Aortic Valve Implantation Devices 80
Cardica 81
Anastomosis Assist Devices 81
Cook Medical 82
Pre-shaped Guidewires 82
CryoLife 83
Mechanical Heart Valve Devices 83
Tissue Heart Valve Devices 84
Edwards LifeSciences 85
Transcatheter Heart Valve Replacement Device 85
Getinge 87
Endoscopic Vessel Harvesting Devices 87
Intra-Aortic Balloon Pump Devices 88
Haemonetics 90
Autotransfusion Devices 90
LivaNova 91
On-Pump Coronary Artery Bypass Devices 91
Ventricular Assist Devices 93
Medtronic 94
On-Pump Coronary Artery Bypass Devices 94
Ventricular Assist Devices 95
Pre-shaped Guidewires 97
Teleflex 98
Intra-Aortic Balloon Pump Devices 98
Terumo 100
On-Pump Coronary Artery Bypass Devices 100
Endoscopic Vessel Harvesting Device 101
4.4 CLINICAL TRIALS 102
4.4.1 Abbott 102
4.4.2 CryoLife 106
4.4.3 Edwards LifeSciences 107
4.4.4 Medtronic 112
GLOBAL CARDIAC SURGERY AND HEART VALVE DEVICE MARKET OVERVIEW 113
5.1 INTRODUCTION 113
5.2 MARKET OVERVIEW & TREND ANALYSIS 115
5.2.1 By Segment 115
5.2.2 By Region 120
5.3 DRIVERS AND LIMITERS 123
5.3.1 Market Drivers 123
5.3.2 Market Limiters 124
5.4 COMPETITIVE MARKET SHARE ANALYSIS 126
5.5 MERGERS AND ACQUISITIONS 134
5.6 COMPANY PROFILES 136
5.6.1 Abbott 136
5.6.2 Abiomed 138
5.6.3 AtriCure 139
5.6.4 Boston Scientific 140
5.6.5 CryoLife 141
5.6.6 Edwards LifeSciences 142
5.6.7 LivaNova 143
5.6.8 Getinge 144
5.6.9 Medtronic 145
5.6.10 Teleflex 145
5.6.11 Terumo 147
5.7 SWOT ANALYSIS 148
5.7.1 Abbott 149
5.7.2 Abiomed 150
5.7.3 AtriCure 151
5.7.4 Boston Scientific 152
5.7.5 CryoLife 153
5.7.7 Edwards LifeSciences 154
5.7.8 LivaNova 155
5.7.10 Getinge 156
5.7.11 Medtronic 157
5.7.12 Teleflex 158
5.7.13 Terumo 159
TISSUE HEART VALVE MARKET 160
6.1 EXECUTIVE SUMMARY 160
6.1.1 Global Tissue Heart Valve Market Overview 160
6.1.2 Competitive Analysis 163
6.1.3 Procedures Included 164
6.1.4 Markets Included 165
6.1.5 Regions Included 166
6.2 INTRODUCTION 168
6.3 PROCEDURE NUMBERS 169
6.3.1 Tissue Heart Valve Procedures by Valve 170
6.3.1.1 Aortic Valve Procedures 182
6.3.1.2 Mitral Valve Procedures 192
6.3.1.3 Pulmonary Valve Procedures 202
6.3.1.4 Tricuspid Valve Procedures 212
6.4 MARKET OVERVIEW 222
6.4.1 By Segment 223
6.4.2 By Region 225
6.5 MARKET ANALYSIS AND FORECAST 227
6.5.1 Total Tissue Heart Valve Market 227
6.5.2 Stented Tissue Heart Valve Market 231
6.5.3 Stentless Tissue Heart Valve Market 235
6.5.4 Sutureless/Rapid Deployment Tissue Heart Valve Market 239
6.6 DRIVERS AND LIMITERS 243
6.6.1 Market Drivers 243
6.6.2 Market Limiters 244
6.7 COMPETITIVE MARKET SHARE ANALYSIS 245
MECHANICAL HEART VALVE MARKET 248
7.1 EXECUTIVE SUMMARY 248
7.1.1 Global Mechanical Heart Valve Market Overview 248
7.1.2 Competitive Analysis 250
7.1.3 Procedures Included 251
7.1.4 Regions Included 252
7.2 INTRODUCTION 254
7.3 PROCEDURE NUMBERS 255
7.3.1 Mechanical Heart Valve Procedures by Valve 256
7.3.1.1 Aortic Valve Procedures 268
7.3.1.2 Mitral Valve Procedures 278
7.3.1.3 Pulmonary Valve Procedures 288
7.3.1.4 Tricuspid Valve Procedures 298
7.4 MARKET ANALYSIS AND FORECAST 308
7.5 DRIVERS AND LIMITERS 313
7.5.1 Market Drivers 313
7.5.2 Market Limiters 314
7.6 COMPETITIVE MARKET SHARE ANALYSIS 315
ANNULOPLASTY REPAIR DEVICE MARKET 318
8.1 EXECUTIVE SUMMARY 318
8.1.1 Global Annuloplasty Repair Device Market Overview 318
8.1.2 Competitive Analysis 320
8.1.3 Procedures Included 321
8.1.4 Regions Included 322
8.2 INTRODUCTION 324
8.3 PROCEDURE NUMBERS 325
8.3.1 Annuloplasty Repair Procedures by Valve 326
8.3.1.1 Mitral Valve Procedures 338
8.3.1.3 Tricuspid Valve Procedures 348
8.4 MARKET ANALYSIS AND FORECAST 358
8.5 DRIVERS AND LIMITERS 363
8.5.1 Market Drivers 363
8.5.2 Market Limiters 363
8.6 COMPETITIVE MARKET SHARE ANALYSIS 365
TRANSCATHETER MITRAL VALVE REPAIR DEVICE MARKET 368
9.1 EXECUTIVE SUMMARY 368
9.1.1 Global Transcatheter Mitral Valve Repair Device Market Overview 368
9.1.2 Competitive Analysis 370
9.1.3 Regions Included 371
9.2 INTRODUCTION 373
9.3 PROCEDURE NUMBERS 374
9.4 MARKET ANALYSIS AND FORECAST 386
9.5 DRIVERS AND LIMITERS 392
9.5.1 Market Drivers 392
9.5.2 Market Limiters 393
9.6 COMPETITIVE MARKET SHARE ANALYSIS 394
TRANSCATHETER AORTIC VALVE IMPLANTATION DEVICE MARKET 397
10.1 EXECUTIVE SUMMARY 397
10.1.1 Global Transcatheter Aortic Valve Implantation Device Market Overview 397
10.1.2 Competitive Analysis 400
10.1.3 Regions Included 401
10.2 INTRODUCTION 403
10.3 PROCEDURE NUMBERS 404
10.4 MARKET ANALYSIS AND FORECAST 416
10.5 DRIVERS AND LIMITERS 422
10.5.1 Market Drivers 422
10.5.2 Market Limiters 423
10.6 COMPETITIVE MARKET SHARE ANALYSIS 424
ON-PUMP CORONARY ARTERY BYPASS DEVICE MARKET 429
11.1 EXECUTIVE SUMMARY 429
11.1.1 Global On-Pump Coronary Artery Bypass Device Market Overview 429
11.1.2 Competitive Analysis 432
11.1.3 Procedures Included 433
11.1.4 Markets Included 434
11.1.5 Regions Included 435
11.2 INTRODUCTION 437
11.3 PROCEDURE NUMBERS 438
11.3.1 CABG Procedures by Support Type 439
11.3.1.1 ONCAB Procedures 451
11.3.1.3 OPCAB Procedures 461
11.4 MARKET OVERVIEW 471
11.4.1 By Segment 472
11.4.2 By Region 474
11.5 MARKET ANALYSIS AND FORECAST 476
11.5.1 ONCAB Disposables Market 476
11.5.2 Perfusion System Market 480
11.6 DRIVERS AND LIMITERS 485
11.6.1 Market Drivers 485
11.6.2 Market Limiters 486
11.7 COMPETITIVE MARKET SHARE ANALYSIS 487
OFF-PUMP CORONARY ARTERY BYPASS DEVICE MARKET 491
12.1 EXECUTIVE SUMMARY 491
12.1.1 Global Off-Pump Coronary Artery Bypass Device Market Overview 491
12.1.2 Competitive Analysis 494
12.1.3 Procedures Included 495
12.1.4 Markets Included 496
12.1.5 Regions Included 497
12.2 INTRODUCTION 499
12.3 PROCEDURE NUMBERS 500
12.3.1 CABG Procedures by Support Type 501
12.3.1.1 ONCAB Procedures 513
12.3.1.3 OPCAB Procedures 523
12.4 MARKET OVERVIEW 533
12.4.1 By Segment 533
12.4.2 By Region 535
12.5 MARKET ANALYSIS AND FORECAST 537
12.5.1 Total Off-Pump Coronary Artery Bypass (OPCAB) Device Market 537
12.5.2 Stabilizer Device Market 541
12.5.3 Positioner Device Market 545
12.6 DRIVERS AND LIMITERS 549
12.6.1 Market Drivers 549
12.6.2 Market Limiters 550
12.7 COMPETITIVE MARKET SHARE ANALYSIS 551
AUTOTRANSFUSION DEVICE MARKET 554
13.1 EXECUTIVE SUMMARY 554
13.1.1 Global Autotransfusion Device Market Overview 554
13.1.2 Competitive Analysis 557
13.1.3 Markets Included 558
13.1.4 Regions Included 559
13.2 INTRODUCTION 561
13.3 PROCEDURE NUMBERS 562
13.4 MARKET OVERVIEW 574
13.4.1 By Segment 574
13.4.2 By Region 576
13.5 MARKET ANALYSIS AND FORECAST 578
13.5.1 Autotransfusion Machine Market 578
13.5.2 Autotransfusion Disposables Market 583
13.6 DRIVERS AND LIMITERS 587
13.6.1 Market Drivers 587
13.6.2 Market Limiters 587
13.7 COMPETITIVE MARKET SHARE ANALYSIS 589
ENDOSCOPIC VESSEL HARVESTING DEVICE MARKET 592
14.1 EXECUTIVE SUMMARY 592
14.1.1 Global Endoscopic Vessel Harvesting Device Market Overview 592
14.1.2 Competitive Analysis 595
14.1.3 Procedures Included 596
14.1.4 Regions Included 597
14.2 INTRODUCTION 599
14.3 PROCEDURE NUMBERS 600
14.4 MARKET ANALYSIS AND FORECAST 612
14.5 DRIVERS AND LIMITERS 617
14.5.1 Market Drivers 617
14.5.2 Market Limiters 617
14.6 COMPETITIVE MARKET SHARE ANALYSIS 618
ANASTOMOSIS ASSIST DEVICE MARKET 621
15.1 EXECUTIVE SUMMARY 621
15.1.1 Global Anastomosis Assist Device Market Overview 621
15.1.2 Competitive Analysis 624
15.1.3 Procedures Included 625
15.1.4 Regions Included 626
15.2 INTRODUCTION 628
15.3 PROCEDURE NUMBERS 629
15.4 MARKET ANALYSIS AND FORECAST 641
15.5 DRIVERS AND LIMITERS 647
15.5.1 Market Drivers 647
15.5.2 Market Limiters 648
15.6 COMPETITIVE MARKET SHARE ANALYSIS 649
VENTRICULAR ASSIST DEVICE MARKET 652
16.1 EXECUTIVE SUMMARY 652
16.1.1 Global Ventricular Assist Device Market Overview 652
16.1.2 Competitive Analysis 654
16.1.3 Procedures Included 655
16.1.4 Markets Included 656
16.1.5 Regions Included 657
16.2 INTRODUCTION 659
16.3 PROCEDURE NUMBERS 661
16.3.1 Ventricular Assist Device Procedures by Device Type 662
16.3.1.1 Percutaneous VAD Procedures 674
16.3.1.3 Implantable VAD Procedures 684
16.4 MARKET OVERVIEW 694
16.4.1 By Segment 695
16.4.2 By Region 697
16.5 MARKET ANALYSIS AND FORECAST 699
16.5.1 Total Ventricular Assist Device (VAD) Market 699
16.5.2 Percutaneous VAD Market 703
16.5.3 Implantable VAD Market 707
16.6 DRIVERS AND LIMITERS 711
16.6.1 Market Drivers 711
16.6.2 Market Limiters 711
16.7 COMPETITIVE MARKET SHARE ANALYSIS 713
INTRA-AORTIC BALLOON PUMP DEVICE MARKET 721
17.1 EXECUTIVE SUMMARY 721
17.1.1 Global Intra-Aortic Balloon Pump Device Market Overview 721
17.1.2 Competitive Analysis 724
17.1.3 Markets Included 725
17.1.4 Regions Included 726
17.2 INTRODUCTION 728
17.3 PROCEDURE NUMBERS 729
17.4 MARKET OVERVIEW 741
17.4.1 By Segment 742
17.4.2 By Region 744
17.5 MARKET ANALYSIS AND FORECAST 746
17.5.1 Intra-Aortic Balloon Pump (IABP) Catheter Market 746
17.5.2 Intra-Aortic Balloon Pump (IABP) Console Market 751
17.6 DRIVERS AND LIMITERS 755
17.6.1 Market Drivers 755
17.6.2 Market Limiters 755
17.7 COMPETITIVE MARKET SHARE ANALYSIS 757
PATENT FORAMEN OVALE CLOSURE DEVICE MARKET 760
18.1 EXECUTIVE SUMMARY 760
18.1.1 Global Patent Foramen Ovale Closure Device Market Overview 760
18.1.2 Competitive Analysis 763
18.1.3 Regions Included 764
18.2 INTRODUCTION 766
18.3 PROCEDURE NUMBERS 767
18.4 MARKET ANALYSIS AND FORECAST 779
18.5 DRIVERS AND LIMITERS 784
18.5.1 Market Drivers 784
18.5.2 Market Limiters 784
18.6 COMPETITIVE MARKET SHARE ANALYSIS 786
ATRIAL & VENTRICULAR SEPTAL DEFECT CLOSURE DEVICE MARKET 789
19.1 EXECUTIVE SUMMARY 789
19.1.1 Global Atrial & Ventricular Septal Defect Closure Device Market Overview 789
19.1.2 Competitive Analysis 792
19.1.3 Procedures Included 793
19.1.4 Markets Included 794
19.1.5 Regions Included 795
19.2 INTRODUCTION 797
19.3 PROCEDURE NUMBERS 798
19.3.1 Total Atrial & Ventricular Septal Defect Closure Procedures 798
19.3.2 Atrial Septal Defect Closure Procedures 810
19.3.3 Ventricular Septal Defect Closure Procedures 820
19.4 MARKET OVERVIEW 830
19.4.1 By Segment 831
19.4.2 By Region 833
19.5 MARKET ANALYSIS AND FORECAST 835
19.5.1 Total Atrial & Ventricular Septal Defect Closure Market 835
19.5.2 Atrial Septal Defect Closure Device Market 839
19.5.3 Ventricular Septal Defect Closure Device Market 843
19.6 DRIVERS AND LIMITERS 847
19.6.1 Market Drivers 847
19.6.2 Market Limiters 847
19.7 COMPETITIVE MARKET SHARE ANALYSIS 848
LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET 851
20.1 EXECUTIVE SUMMARY 851
20.1.1 Global Left Atrial Appendage Closure Device Market Overview 851
20.1.2 Competitive Analysis 854
20.1.3 Procedures Included 855
20.1.4 Markets Included 856
20.1.5 Regions Included 857
20.2 INTRODUCTION 859
20.3 PROCEDURE NUMBERS 860
20.3.1 Left Atrial Appendage Closure Procedures by Device Type 861
20.3.1.1 Endocardial Left Atrial Appendage Closure Procedures 873
20.3.1.3 Epicardial Left Atrial Appendage Closure Procedures 883
20.4 MARKET OVERVIEW 893
20.4.1 By Segment 894
20.4.2 By Region 896
20.5 MARKET ANALYSIS AND FORECAST 898
20.5.1 Endocardial Device Market 898
20.5.2 Epicardial Device Market 902
20.6 DRIVERS AND LIMITERS 907
20.6.1 Market Drivers 907
20.6.2 Market Limiters 908
20.7 COMPETITIVE MARKET SHARE ANALYSIS 909
PRE-SHAPED GUIDEWIRE MARKET 916
21.1 EXECUTIVE SUMMARY 916
21.1.1 Global Pre-shaped Guidewire Market Overview 916
21.1.2 Competitive Analysis 919
21.1.3 Regions Included 920
21.2 INTRODUCTION 922
21.3 MARKET ANALYSIS AND FORECAST 923
21.4 DRIVERS AND LIMITERS 928
21.4.1 Market Drivers 928
21.4.2 Market Limiters 928
21.5 COMPETITIVE MARKET SHARE ANALYSIS 930
CEREBRAL EMBOLIC PROTECTION DEVICE MARKET 932
22.1 EXECUTIVE SUMMARY 932
22.1.1 Global Cerebral Embolic Protection Device Market Overview 932
22.1.2 Competitive Analysis 934
22.1.3 Procedures Included 935
22.1.4 Regions Included 936
22.2 INTRODUCTION 938
22.3 PROCEDURE NUMBERS 939
22.4 MARKET ANALYSIS AND FORECAST 948
22.5 DRIVERS AND LIMITERS 953
22.5.1 Market Drivers 953
22.5.2 Market Limiters 953
22.6 COMPETITIVE MARKET SHARE ANALYSIS 955
ABBREVIATIONS 957
Companies Analyzed in this Study |
||||
|---|---|---|---|---|
|
|
|||
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
| Report Summary | FREE |
Cardiac Surgery Market Size, Share & COVID19 Impact Analysis | Global | 2021-2027 | MedSuite | Includes: Tissue Heart Valve Market, TAVI/TAVR Market, and 15 more
$9,995 – $13,995
The global market for cardiac surgery and heart valve devices includes tissue heart valves, mechanical heart valves, annuloplasty repair devices, transcatheter mitral valve repair (TMVr) devices, transcatheter aortic heart valve implantation (TAVI) devices, on-pump coronary artery bypass (ONCAB) devices, off-pump coronary artery bypass (OPCAB) devices, autotransfusion (AD) devices, endoscopic vessel harvesting (EVH) devices, anastomosis assist devices (AADs), ventricular assist devices (VADs), intra-aortic balloon pump (IABP) devices, patent foramen ovale (PFO) devices, atrial and ventricular septal defect (ASD and VSD) devices, left atrial appendage closure (LAA) devices, preshaped guidewires and cerebral embolic protection devices.
- 2021
- 10 Years
- Global
- 958
- MedSuite
Related Reports
